Our Mission
The Institute for Stem Cell and Regenerative Medicine (ISCRM) is committed to the ethical pursuit of basic research to unleash the enormous potential of stem cells and thereby develop therapies and cures.
The Institute, founded in March 2006, consists of a world-class team of over 130 faculty conducting basic research on stem and progenitor cells. The Institute is linked by the shared commitment of the faculty to leverage this research to develop improved therapies, and cures, for patients.
Read more about ISCRM's mission
In the News
Major improvements made in engineering heart repair patches from stem cells.
ISCRM Manager receives Service Excellence Award
July 15, 2009
Stem-Cell Research in Seattle -- KUOW/NPR radio interview
Link to audio
Research Highlights
Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.
Read the Cell Stem Cell article.
2009 ISCRM Research Awards Awarded
ISCRM is pleased to announce the 2009 awardees of the Tietze Young Scientist and the McCabe Research Awards.
To read more...
New High Throughput Screening Facility Opens
An academic screening center within the Institute for Stem Cell and Regenerative Medicine
at UW Medicine's South Lake Union site, called the "Quellos High Throughput Screening Core"
has just become operational. Specializing in RNA Interference and Chemical (Small Molecule)
Screening technologies, the core facility will serve academia, biotechnology and bio-pharma
organizations across the Pacific Northwest region.
For more information, please click here
Quellos Research Acceleration Awards available to subsidize screening
The HTS Core will grant to select UW investigators with acceptable projects an award to subsidize their screening efforts. Please visit the provided link for more information about the Quellos Research Acceleration Awards.
Click here for more info.
